5 Articles on ASC Managed Care Contract Negotiation
What is the Most Important Thing ASCs Should Do for Managed Care Contracting?
I. Naya Kehayes, MPH, managing principal and CEO of EVEIA HEALTH Consulting & Management, weighs in on the most important strategy of contracting success.
Payment Predicament: The Evolution of Managed Care Contracting Challenges
Adriaan Epps, abeo vice president of practice management, deconstructs the past, present and future of some of the most difficult aspects of contract negotiation.
5 Methods for All-Star Managed Care Contract Negotiations
Adriaan Epps, abeo vice president of practice management, outlines steps to mitigate barriers to gaining favorable reimbursement rates.
Healthcare Reform: Impact on ASC Managed Care Contracting Next Year
I. Naya Kehayes, MPH, managing principal and CEO of EVEIA HEALTH Consulting & Management describes the impact on contracting that ASC leaders can expect to see from healthcare form.
ASC Implant Carve-Outs: Opportunities, Challenges & 4 Best Practices
Dan Connolly, vice president of payer contracting with Pinnacle III, analyzes the carve-out strategy and offers insight into approaches for the most effective negotiations.
More Articles on Coding and Billing:
8 Statistics on ICD-10 & Provider Concerns
9 Things to Know: Workers Compensation Research Institute "Payments to Ambulatory Surgery Centers" Report
89% of Physician Practices Want to Upgrade Billing, Collections Processes
© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- Drug-resistant tuberculosis alarms health officials — 4 notes
- Preventing & combating healthcare fraud: An ongoing process for ASCs
- Dr. Thomas Frieden talks opioids, antibiotic resistance & more with MedPage Today during final days at CDC
- Orphan drugs' annual average price tag cost $88.4k more than mainstream drugs in 2014: 4 key statistics
- GI leader to know: Dr. Robert Levine of the Boulder Medical Center